MYCO — Mydecine Innovations Share News
0.000.00%
- CA$0.62m
- CA$7.09m
REG-Mydecine Innovations Group Inc: Mydecine Announces Filing of Q3 Financial Statements
AnnouncementREG-Mydecine Innovations Group Inc: Suspension of Trading
AnnouncementREG-Mydecine Innovations Group Inc: MYDECINE ANNOUNCES FILING OF UNAUDITED INTERIM FINANCIAL STATEMENTS
AnnouncementREG-Mydecine Innovations Group Inc: Annual and Q1 Financial Statements
AnnouncementREG-Mydecine Innovations Group Inc: Doc re: Bl-Weekly Status Report
AnnouncementREG-Mydecine Innovations Group Inc: Bl-Weekly Status Report
AnnouncementREG-Mydecine Innovations Group Inc: Mydecine Provides Bl-Weekly Status Report
AnnouncementREG-Mydecine Innovations Group Inc: Mydecine applies for management cease trade order
AnnouncementREG-Mydecine Innovations Group Inc: Restructuring transactions and annual general and special meeting
AnnouncementREG-Mydecine Innovations Group Inc: Management cease trade order
AnnouncementREG-Mydecine Innovations Group Inc: Total Voting Rights
AnnouncementREG-Mydecine Innovations Group Inc: Closing of Share for Debt Settlement
AnnouncementREG-Mydecine Innovations Group Inc: SHARE FOR DEBT SETTLEMENT
AnnouncementREG-Mydecine Innovations Group Inc: Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement
AnnouncementREG-Mydecine Innovations Group Inc: Total Voting Rights
AnnouncementREG-Mydecine Innovations Group Inc: Share for Debt Settlement
AnnouncementREG-Mydecine Innovations Group Inc: Total Voting Rights
AnnouncementREG-Mydecine Innovations Group Inc: Closing of Share for Debt Settlement
AnnouncementREG-Mydecine Innovations Group Inc: Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
Announcement